Skip to main content
OpenTrials

Clinical trial condition

Psoriasis

Explore clinical trials studying Psoriasis. Study availability and eligibility vary by location and protocol.

1,174 public trials 112 recruiting studies
Refine in advanced search Browse all conditions

Psoriasis trial results

Active, Not Recruiting

Canadian Real World Evidence Study of Brodalumab in Plaque Psoriasis to Understand the Impact on Quality of Life and Work Productivity

NCT05132231

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • CARE Site 42 Calgary, Alberta, Canada
  • CARE Site 26 Calgary, Alberta, Canada
  • CARE Site 15 Calgary, Alberta, Canada
  • CARE Site 18 Edmonton, Alberta, Canada
View all 42 locations
View Trial Details
Active, Not Recruiting

An Open-label, Single-dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Brodalumab in Pediatric Subjects

NCT03240809

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • Bausch Site 003 San Diego, California, United States
  • Bausch Site 002 Miami, Florida, United States
  • Bausch Site 004 Miami, Florida, United States
  • Bausch Site 005 Henderson, Nevada, United States
View Trial Details
Active, Not Recruiting

Study to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Psoriasis Treated With Subcutaneous Risankizumab Injection According to Standard of Care

NCT04780516

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • Duplicate_Kaplan Medical Center /ID# 226569 Rehovot, Central District, Israel
  • Leumit /ID# 252029 Rehovot, Central District, Israel
  • HaEmek Medical Center /ID# 251040 Afula, Haifa District, Israel
  • Shaare Zedek Medical Center /ID# 247319 Jerusalem, Israel
View Trial Details
Active, Not Recruiting

Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 6 and 17 Years With Moderate to Severe Plaque Psoriasis Treated With Subcutaneous (SC) Injection of Risankizumab Who Have Completed Participation in Study M19-977

NCT04862286

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • UAB Department of Dermatology /ID# 252305 Birmingham, Alabama, United States
  • First OC Dermatology /ID# 226942 Fountain Valley, California, United States
  • Integrative Skin Science and Research /ID# 226108 Sacramento, California, United States
  • University of California San Diego - Rady Children's Hospital San Diego /ID# 252348 San Diego, California, United States
View all 41 locations
View Trial Details
Active, Not Recruiting

A Clinical Study of TQH2929 Injection in Treatment With Generalized Pustular Psoriasis (GPP)

NCT06433531

Conditions
Generalized Pustular Psoriasis, Psoriasis, Skin Diseases, +2 more
Locations
  • Peking University First Hospital Beijing, Beijing Municipality, China
  • Dermatology Hospital of Southern Medical Universitye Guangzhou, Guangdong, China
  • The First Hospital of Hebei Medical University Shijiazhuang, Hebei, China
  • The Second Hospital of Hebei Medical University Shijiazhuang, Hebei, China
View Trial Details

Related conditions